Schedule 13G ownership disclosure

AEON Biopharma, Inc.

Class A ordinary shares, par value $0.0001 per share · CUSIP: 00791X100

Event date: 2024-12-31

Filing-level shares
2,762,688
Percent of class
6.9%
  • Polar Asset Management Partners Inc.

    Shares: 2,762,688 · Class: 6.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001326389-25-000109
Form type
SCHEDULE 13G/A
Filer
AEON Biopharma, Inc.
CIK
CIK 1837607
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub